Showing results (4201-4210 of 5,702) with videos related to
Sort By:
Pageof 571
The Oncologist|July 3, 2026
The Impact of Relative Dose Intensity on pCR in Neoadjuvant Chemotherapy of Muscle-Invasive Urothelial Cancer: a Multicentre Retrospective StudyGiuseppe Neola, Fabiano Flauto, Carmine Caso, et al.The Oncologist|July 2, 2026
Molecular Tumor Board-Guided Osimertinib Therapy in EGFR L858R/Q701L-Mutant Lung Adenocarcinoma Supported by Functional ValidationCorinna Albers-Leischner, Matthias Ritgen, Finn-Ole Paulsen, et al.The Oncologist|July 9, 2026
Anti-HER2 Therapies in Metastatic Colorectal Cancer: A Systematic Review and Meta-AnalysisSimone Rota, Paola Di Nardo, Emma Zottarelli, et al.The Oncologist|July 11, 2026
GLP-1 receptor agonist use and overall survival among women with type 2 diabetes and breast cancer: a retrospective cohort studyRebecca A Nelson, Ying-Chuen Lai, Sung H Kil, et al.The Oncologist|July 11, 2026
Novel Risk Scoring System for Patients with Metastatic Castration Resistant Prostate Cancer Treated with Lutetium-177-PSMA-617Margo B Gerke, Angelo Marra, Michelle Jayaraj, et al.The Oncologist|July 14, 2026
Zanidatamab versus Trastuzumab with or without PD-1 blockade in HER2-positive metastatic gastric cancer: a reconstructed patient-level pooled analysisFederico Nichetti, Floriana Nappo, Francesca Bof, et al.The Oncologist|July 25, 2026
Effectiveness and Safety of Immunotherapy in Advanced NSCLC with Pericardial Effusions: A Global Retrospective Multicenter StudyTalal El Zarif, Sarah Abou Alaiwi, Amin H Nassar, et al.The Oncologist|July 31, 2026
Genomic landscape and clinical characteristics of ERBB2/HER2-mutated colorectal cancersMuhammed Dogukan Aksu, Paola Zinser Peniche, Doga Kahramangil Baytar, et al.The Oncologist|July 26, 2026
EGFR-mutant NSCLC progressing on first-line osimertinib: rebiopsy in real-world and impact of second-line therapies (the 'Rebiopsy on osi' Study)Eleonora Gariazzo, Francesca Colamartini, Ornella Cantale, et al.Pageof 571